שמפו לשיער צבוע Izraelis - hebrajų - Ministry of Health

שמפו לשיער צבוע

אבון קוסמטיקה ישראל בעמ - חפיפת שיער

אינספרה 25 מג Izraelis - hebrajų - Ministry of Health

אינספרה 25 מג

pfizer pfe pharmaceuticals israel ltd - eplerenone - טבליות מצופות פילם - eplerenone 25 mg - eplerenone

אינספרה 50 מג Izraelis - hebrajų - Ministry of Health

אינספרה 50 מג

pfizer pfe pharmaceuticals israel ltd - eplerenone - טבליות מצופות פילם - eplerenone 50 mg - eplerenone

דרקסין תמיסה להזרקה וטרינרי Izraelis - hebrajų - Ministry of Health

דרקסין תמיסה להזרקה וטרינרי

zoetis israel holding b.v., israel - tulathromycin - תמיסה להזרקה - tulathromycin 100 mg/ml

אפרקס 1000 Izraelis - hebrajų - Ministry of Health

אפרקס 1000

j-c health care ltd - recombinant human erythropoietin - תמיסה להזרקה - recombinant human erythropoietin 1000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of severe anemia associated with chronic renal failure, anemia in zidovudine treated hiv infected patients, anemia in cancer patients on chemotherapy.to increase the yield of autologous blood from patients in a predonation programme initiated to avoid the use of homologous blood. treatment is indicated in patients with moderate anemia (packed cell volume (pcv) approximately 33 to 39% , no iron deficiency) if blood conserving procedures are not available or insufficient either: a: when the scheduled major elective surgery requires a large volume of blood ( 4 or more units of blood for females or 5 or more units for males) or b: when the period necessary to obtain the required volume of autologous blood is too short. perisurgery: reduction of allogeneic blood transfusion in surgery patients : eprex is indicated for the treatment of anemic patients (hemoglobin 9-11 g/dl) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions. eprex is indicat

אפרקס 2000 Izraelis - hebrajų - Ministry of Health

אפרקס 2000

j-c health care ltd - recombinant human erythropoietin - תמיסה להזרקה - recombinant human erythropoietin 2000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of severe anemia associated with chronic renal failure, anemia in zidovudine treated hiv infected patients, anemia in cancer patients on chemotherapy.to increase the yield of autologous blood from patients in a predonation programme initiated to avoid the use of homologous blood. treatment is indicated in patients with moderate anemia (packed cell volume (pcv) approximately 33 to 39% , no iron deficiency) if blood conserving procedures are not available or insufficient either: a: when the scheduled major elective surgery requires a large volume of blood ( 4 or more units of blood for females or 5 or more units for males) or b: when the period necessary to obtain the required volume of autologous blood is too short. perisurgery: reduction of allogeneic blood transfusion in surgery patients : eprex is indicated for the treatment of anemic patients (hemoglobin 9-11 g/dl) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions. eprex is indicat